Seyed-Hossein Khademi

Seyed-Hossein Khademi

Auto-generated profile, based on publicly available information

Seyed-Hossein Khademi

Department of Anesthesiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2021 in Anesthesiology and Pain Medicine
Verified
Journal Article
Open access
PDF file
Amber EdinoffAmber Edinoff
Amber Edinoff
JFJoseph S. Fitz-Gerald
Joseph S. Fitz-Gerald
KHKrisha Andrea A. Holland
Krisha Andrea A. Holland
JRJohnnie G. Reed
Johnnie G. Reed
SMSarah E. Murnane
Sarah E. Murnane
Alan David KayeAlan David Kaye
Alan David Kaye
: The potential for misuse, overdose, and chronic use has led researchers to look for other methods to decrease opioid consumption in patients with acute and chronic pain states. The use of peripheral nerve blocks for surgery has gained increasing popularity as it minimizes peripheral pain signals from the nociceptors of local tissue sustaining trauma and inflammation from surgery. The individualization of peripheral nerve blocks using adjuvant drugs has the potential to improve patient outcomes and reduce chronic pain. The major limitations of peripheral nerve blocks are their limited duration of action and dose-dependent adverse effects. Adjuvant drugs for peripheral nerve blocks show increasing potential as a solution for postoperative and chronic pain with their synergistic effects to increase the duration of action and decrease the required dosage of local anesthetic. N-methyl-d-aspartate (NMDA) receptor antagonists are a viable option for patients with opioid resistance and neuropathic pain due to their affinity to the neurotransmitter glutamate, which is released when patients experience a noxious stimulus. Neostigmine is a cholinesterase inhibitor that exerts its effect by competitively binding at the active site of acetylcholinesterase, which prevents the hydrolysis of acetylcholine and subsequently retaining acetylcholine at the nerve terminal. Epinephrine, also known as adrenaline, can potentially be used as an adjuvant to accelerate and prolong analgesic effects in digital nerve blocks. The theorized role of sodium bicarbonate in local anesthetic preparations is to increase the pH of the anesthetic. The resulting alkaline solution enables the anesthetic to more readily exist in its un-ionized form, which more efficiently crosses lipid membranes of peripheral nerves. However, more research is needed to show the efficacy of these adjuvants for nerve block prolongation as studies have been either mixed or have small sample sizes.

1 November 2022 in Anesthesiology and Pain Medicine
Verified
Journal Article
Open access
PDF file
KMKhalid M. Malik
Khalid M. Malik
ANAriana Nelson
Ariana Nelson
TCTing-Hsuan Chiang
Ting-Hsuan Chiang
FIFarnad Imani
Farnad Imani
SKSeyed-Hossein Khademi
Seyed-Hossein Khademi
: Low back pain (LBP) is the leading cause of pain and debility worldwide and the most frequent reason for work-related disability. Global expenditures related to LBP are staggering and amount to billions of dollars each year in the United States alone. Yet, despite the considerable healthcare resources consumed, the care provided to patients with LBP has regularly been cited as both ineffective and exorbitant. Among the myriad reasons for this suboptimal care, the current approach to evaluation and management of patients with LBP is a likely contributor and is hitherto un-investigated. Following the current methodology, over 90% of patients with LBP are provided with no specific diagnosis, are managed inconsistently, and receive no express preventative care. We believed that this approach added costs and promoted chronic unresolved pain and disability. This narrative review highlights problems with the current methodology, proposes a novel concept for categorizing patients with LBP, and recommends strategies for improvement. Stratifying patients according to the etiology, in lieu of the prospects for morbidity, the strategy proposed in this article may help ascertain the cause of patient’s LBP early, consolidate treatments, permit timely preventative measures, and, as a result, may improve patient outcomes.

9 May 2022 in Anesthesiology and Pain Medicine
Verified
Journal Article
Open access
PDF file
Amber EdinoffAmber Edinoff
Amber Edinoff
SKSarah Kaufman
Sarah Kaufman
EAE. Saunders Alpaugh
E. Saunders Alpaugh
JLJesse Lawson
Jesse Lawson
TATucker Apgar
Tucker Apgar
Alan David KayeAlan David Kaye
Alan David Kaye
: Over the last several decades, opioid diversion, misuse, and over-prescription have run rampant in the United States. Spinal cord stimulation (SCS) has been FDA approved for treatment for a primary indication of neuropathic limb pain that is resistant to more conservative medical therapy. The disorders qualified for treatment include neuropathic, post-surgical, post-amputation, osteodegenerative, and pain related to vascular disease. Some of the most frequently cited conditions for treatment of SCS include failed back surgery syndrome, complex regional pain syndrome (CRPS) Type I and Type II, and post-herpetic neuralgias. Developments in SCS systems have led to the differentiation between the delivered electromechanical waveform patterns, including tonic, burst, and high-frequency. Burst SCS mitigates traditional paresthesia due to expedited action potential and offers improved pain relief. Burst SCS has been shown in available studies to be non-inferior to the traditional SCS, which can cause pain paresthesia in patients who already have chronic pain. Burst SCS does not seem to cause or need the paresthesia seen in traditional SCS, making SCS not tolerable to patients. Moreover, some studies suggest that burst SCS may decrease opioid consumption in patients with chronic pain. This can make burst SCS an extremely useful tool in the battle against chronic pain and the raging opioid epidemic. As of now, more research needs to be performed to further delineate the effectiveness and long-term safety of this device.

22 December 2021 in Anesthesiology and Pain Medicine
Verified
Journal Article
Open access
PDF file
ECEric Y. Chen
Eric Y. Chen
SBSascha S. Beutler
Sascha S. Beutler
Alan David KayeAlan David Kaye
Alan David Kaye
Amber EdinoffAmber Edinoff
Amber Edinoff
SKSeyed-Hossein Khademi
Seyed-Hossein Khademi
WSWinston J. Suh
Winston J. Suh
: Neuropathic pain is a challenge for physicians to treat and often requires a multimodal approach with both pharmacologic and lifestyle interventions. Mirogabalin, a potent, selective ligand of the α2δ-1 and α2δ-2 subunits of voltage-gated calcium channels (VGCCs), provides analgesia by inhibiting neurotransmitter release at the presynaptic end of the neuron. Mirogabalin offers more sustained analgesia than its gabapentinoid counterparts in addition to a wider safety margin for adverse events. Recent clinical trials of mirogabalin have demonstrated both efficacy and tolerability of the drug for the treatment of diabetic peripheral neuropathic pain and postherpetic neuralgia, leading to its approval in Japan. While still not yet FDA approved, mirogabalin is still in its infancy and offers potential into the treatment of neuropathic pain and its associated comorbidities.

17 March 2021 in Anesthesiology and Pain Medicine
Verified
Journal Article
Open access
PDF file
ABAmnon Berger
Amnon Berger
YLYao Liu
Yao Liu
KJKevin Jin
Kevin Jin
AKAlicia Kaneb
Alicia Kaneb
AWAlexandra Welschmeyer
Alexandra Welschmeyer
IUIvan Urits
Ivan Urits
Context: Abdominal pain is a widespread complaint and is one of the common reasons leading patients to seek medical care, either in emergency situations or with their primary providers. While acute abdominal pain is a better defined, usually surgical condition, chronic abdominal pain requires longer, typically lifelong, therapy. Chronic abdominal pain may also present with acute flares and complications. Here we review seminal and novel evidence discussing the use of acupuncture in the treatment of abdominal pain, indications, and conditions that may benefit from this approach. Evidence Acquisition: Chronic abdominal pain is a common complaint causing significant morbidity and disability and has a hefty price tag attached. Recent studies show it may be prevalent in as much as 25% of the adult population. It is defined as three episodes of severe abdominal pain over the course of three months. Chronic abdominal pain could be the result of chronicity of acute pain or of chronic pain syndromes, most commonly IBD syndromes and IBS. While a plethora of treatments exists for both conditions, these treatments usually fall short of complete symptom control, and there is a need for complementary measures to curb disability and increase the quality of life in these patients. Acupuncture is a form of integrative medicine that has long been used in Chinese and traditional medicine, based on the rebalancing of the patient’s Qi, or Ying/Yang balance. It has been shown to be effective in treating several other conditions, and novel evidence may expand its use into other fields as well. Clinical trials studying acupuncture in chronic pain conditions have been promising, and recent evidence supports the use of abdominal pain in chronic abdominal pain conditions as well. Though not curative, acupuncture is a complementary approach that helps reduce symptoms and improved quality of life. Conclusions: Chronic abdominal pain is a widespread condition, mostly affected by the IBS and IBD spectrum. Etiologies are still being studied for these conditions, and while novel treatment approaches are absolute game changers for these patients, many continue to experience some level of symptoms and disability. Acupuncture may provide further alleviation of these symptoms in select patients, thus improving quality of life, reducing disability, and saving healthcare dollars. It is a largely safe and inexpensive method that may significantly contribute to the quality of life of selected patients.

23 October 2019 in Anesthesiology and Pain Medicine
Verified
Journal Article
Open access
PDF file
FIFarnad Imani
Farnad Imani
PRPoupak Rahimzadeh
Poupak Rahimzadeh
HKHossein Khademi
Hossein Khademi
MZMahnaz Narimani Zamanabadi
Mahnaz Narimani Zamanabadi
KSKambiz Sadegi
Kambiz Sadegi
AAAbouzar Abolfazli
Abouzar Abolfazli
Administration of steroids in the lumbar transforaminal block for lumbar radicular pain is considered one of the preferred treatment methods though it is as ...